Quick Answer
SOLIGENIX, INC. reported Total Revenue of $119.4 thousand for fiscal year 2024.
SOLIGENIX, INC. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | — | $119.4K -85.8% |
$839.4K -11.5% |
$948.9K +15.1% |
$824.3K -65.1% |
$2.36M -49.0% |
| Net Income | -$11.08M -34.0% |
-$8.27M -34.6% |
-$6.14M +55.5% |
-$13.80M -9.9% |
-$12.55M +29.0% |
-$17.69M -89.1% |
| Diluted EPS | -$2.14 +57.0% |
-$4.98 +60.7% |
-$12.66 -163.2% |
-$4.81 -2.6% |
-$4.69 -632.8% |
-$0.64 |
| Total Assets | $9.24M +3.0% |
$8.97M -8.5% |
$9.80M -31.4% |
$14.28M -46.9% |
$26.87M +35.1% |
$19.89M +155.8% |
| Cash and Equivalents | — | — | — | — | $26.04M +39.4% |
$18.68M +244.5% |
| Long-Term Debt | — | $0.00 -100.0% |
$1.01M | $0.00 | — | — |
| Stockholders Equity | $5.29M +28.5% |
$4.12M +63.3% |
$2.52M +202.1% |
-$2.47M -123.0% |
$10.72M +186.6% |
$3.74M +156.8% |
| R&D Expense | $7.49M +43.3% |
$5.22M +57.7% |
$3.31M -58.3% |
$7.94M -3.0% |
$8.19M -16.4% |
$9.80M +20.6% |
| Operating Income | -$11.85M -25.5% |
-$9.44M -22.6% |
-$7.70M +45.9% |
-$14.24M -8.7% |
-$13.10M +29.5% |
-$18.59M -76.3% |
| Gross Profit | — | — | $97.3K -75.6% |
$398.1K +316.3% |
$95.6K -82.2% |
$538.5K -49.3% |
| Shares Outstanding | 10.09M +301.1% |
2.51M +287.6% |
648,761 -77.7% |
2.91M +1.8% |
2.86M -90.7% |
30.64M +40.9% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | June 30, 2024 | $2.3K | -98.9% | -98.0% |
| Net Income | September 30, 2025 | -$2.53M | -47.2% | +6.3% |
| Diluted EPS | September 30, 2025 | -$0.58 | +25.6% | +29.3% |
| Total Assets | September 30, 2025 | $11.29M | +7.8% | +96.1% |
| Cash and Equivalents | March 31, 2022 | $22.88M | -25.1% | -12.2% |
| Long-Term Debt | December 31, 2023 | $1.01M | — | -28.6% |
| Stockholders Equity | September 30, 2025 | $7.60M | +28.0% | +315.4% |
| R&D Expense | September 30, 2025 | $1.58M | +63.5% | -5.6% |
| Operating Income | September 30, 2025 | -$2.58M | -38.3% | +6.6% |
| Gross Profit | September 30, 2023 | $20.0K | -45.5% | -12.7% |
| Shares Outstanding | September 30, 2025 | 9.86M | +329.6% | +181.3% |
- SOLIGENIX, INC. reported Total Revenue of $119.4 thousand for fiscal year 2024.
- SOLIGENIX, INC. showed a decrease of -85.8% in Total Revenue compared to the prior fiscal year.
- SOLIGENIX, INC. reported Net Income of -$11.08 million for fiscal year 2025.
- SOLIGENIX, INC. showed a decrease of -34.0% in Net Income compared to the prior fiscal year.
- SOLIGENIX, INC. reported Diluted EPS of $2.14 per share (loss) for fiscal year 2025.
- SOLIGENIX, INC. showed an increase of +57.0% in Diluted EPS compared to the prior fiscal year.
- SOLIGENIX, INC. reported Total Assets of $9.24 million for fiscal year 2025.
- SOLIGENIX, INC. showed an increase of +3.0% in Total Assets compared to the prior fiscal year.
- SOLIGENIX, INC. reported Cash and Equivalents of $26.04 million for fiscal year 2021.
- SOLIGENIX, INC. showed an increase of +39.4% in Cash and Equivalents compared to the prior fiscal year.
- SOLIGENIX, INC. reported Long-Term Debt of $0.00 for fiscal year 2024.
- SOLIGENIX, INC. showed a decrease of -100.0% in Long-Term Debt compared to the prior fiscal year.
- SOLIGENIX, INC. reported Stockholders Equity of $5.29 million for fiscal year 2025.
- SOLIGENIX, INC. showed an increase of +28.5% in Stockholders Equity compared to the prior fiscal year.
- SOLIGENIX, INC. reported R&D Expense of $7.49 million for fiscal year 2025.
- SOLIGENIX, INC. showed an increase of +43.3% in R&D Expense compared to the prior fiscal year.
- SOLIGENIX, INC. reported Operating Income of -$11.85 million for fiscal year 2025.
- SOLIGENIX, INC. showed a decrease of -25.5% in Operating Income compared to the prior fiscal year.
- SOLIGENIX, INC. reported Gross Profit of $97.3 thousand for fiscal year 2023.
- SOLIGENIX, INC. showed a decrease of -75.6% in Gross Profit compared to the prior fiscal year.
- SOLIGENIX, INC. reported Shares Outstanding of 10.09 million shares for fiscal year 2025.
- SOLIGENIX, INC. showed an increase of +301.1% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: